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WNT signaling is a fundamental molecular pathway in
both embryogenesis and disease. Nephron development
is dependent on WNT signaling. The nephron epithelia
proximal to the collecting duct develop from progenitor
cells in the metanephric mesenchyme. The process involves
formation of proto-epithelial cell aggregates, conversion into
epithelia, and proximal-distal patterning of the nephron. Two
ligands from the WNT family, namely Wnt9b and Wnt4, are
required for nephron differentiation. Recent studies have
addressed the downstream targets of these WNT ligands and
delineated the role of the canonical WNT signaling pathway.
This pathway depends on the intracellular protein b-catenin
and the T cell-specific transcription factor/lymphoid enhancer
factor-1 (TCF/Lef1) family of transcription factors. Selective
b-catenin signaling antagonism inhibits differentiation of
metanephric mesenchymal progenitor cells, while
forced activation triggers a stage progression towards
proto-epithelial aggregates. Nonetheless, activation of the
pathway is transient during epithelial differentiation and
titration of pathway activity may be central for the proper
coordination of differentiation and morphogenesis. We
review current evidence on the WNT/b-catenin/TCF/Lef1
signaling pathway in kidney epithelial development
and discuss the potential implication of non-canonical
WNT signaling and WNT-independent events.
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The Wolffian duct sends off a dorsal branch called the
ureteric bud to initiate mammalian kidney development.
This epithelial structure invades an adjacent blastemal
progenitor cell population called the metanephric mesen-
chyme. The ureteric bud receives signals from the meta-
nephric mesenchyme to undergo branching morphogenesis
and develop into the ureter and collecting duct system.
Reciprocally, the metanephric mesenchyme receives signals
from the branching tips of the ureteric bud, which facilitate
its survival, cellular proliferation, and condensation into
proto-epithelial clusters termed pretubular aggregates, the
direct renal epithelial precursors. Additional events mediate
proximal–distal patterning and terminal differentiation of
these progenitors into all nephron epithelia proximal to the
collecting duct.1,2 The process of nephron differentiation
from epithelial progenitors is recapitulated in vitro when the
metanephric mesenchyme is isolated from rat or mouse
embryos and placed in an organ culture in the presence of
inductive factors. These inductive factors that were originally
derived from the ureteric bud or embryonic spinal cord have
now been characterized more closely on a molecular level.2–8
Remarkably, an activation of the WNT (after the Drosophila
homolog Wingless and the Int-1 [Wnt1] integration site in
virally induced murine breast tumors) signaling pathway
appears to be common to all these inducers.2,9,10
WNT SIGNALING PATHWAYS
Since their discovery in the 1980s, WNT proteins have been
found to be involved in a number of cell type-specific
processes governing development and homeostasis. WNT
proteins belong to a highly conserved family of secreted
growth factors that contain roughly 20 members in
mammals. Although different members of the WNT family
have been identified based on their amino-acid homology,
they display a substantial divergence in their biological effects
on target cells. Intracellular WNT signaling is classified into
‘canonical’ and ‘non-canonical’ pathways. In this context,
these terms refer to whether or not the signaling pathway is
b-catenin-dependent (canonical) or b-catenin-independent
(non-canonical).
b-Catenin is a multifunctional intracellular protein that
is characterized by a core domain containing 12 copies of a
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42-amino-acid ‘armadillo’ motif, named after the Drosophila
ortholog of b-catenin. These repeats generate a positively
charged groove that facilitates b-catenin interaction with
several negatively charged ligands, including adenomatous
polyposis coli and TCF/Lef1 transcription factors.11 In
addition to its intracellular signaling functions, b-catenin
constitutes a central component of adherens junctions, where
it interacts with cadherins and a-catenin.12 A multiprotein
complex called the ‘b-catenin destruction complex’ can
capture intracellular b-catenin by default (Figure 1). This
complex contains the proteins axin, adenomatous poly-
posis coli, and glycogen synthase kinase 3b (GSK3b), which
phosphorylates b-catenin on several N-terminal serine/
threonine residues. Phosphorylated b-catenin is then ubiqui-
tinated and targeted for proteasomal degradation. Therefore,
in the absence of WNT signaling, intracellular b-catenin levels
are kept low through continuous degradation. Once a
canonical WNT ligand binds to a FZD (Frizzled)/LRP
(lipoprotein receptor-related protein) receptor complex on
the cell surface, the b-catenin destruction complex is
inhibited through mechanisms that involve the intracellular
protein Dishevelled. Consequently, b-catenin is no longer
phosphorylated by GSK3b, escapes degradation, accumulates
in the cytoplasm, and is translocated to the nucleus.
There b-catenin interacts with transcription factors of the
TCF/Lef1 family displacing transcriptional repressors of the
TLE/Groucho family. Thereby, b-catenin converts TCF/Lef1
factors from transcriptional repressors into transcriptional
activators. By this rather linear transduction cascade,
WNT ligands act as extracellular switches that turn on cell
type-specific transcriptional programs in their target cells,
which in turn mediate the biological effects of canonical
WNT signaling.12,13
The non-canonical branches of WNT signaling have been
identified more recently.14 Notably, WNT signals have been
implicated in the organization of proximal–distal epithelial
cell polarity across a sheet or tube, a process termed planar
cell polarity (PCP).14,15 Components of the WNT/PCP
pathway also include Frizzled receptors and Dishevelled,
but they are independent of b-catenin stabilization and
TCF/Lef1 signaling. Instead, WNT/PCP signaling involves
the GTPases RhoA and Rac1 as well as Jun N-terminal
kinase. Different WNT ligands have been reported to elicit
differential activity on these signaling branches. For instance,
Wnt3a and Wnt1 signal through the b-catenin/TCF/Lef1
pathway in most cell types, whereas Wnt5a and Wnt11 have
been associated with non-canonical pathways. However, even
for these well-characterized family members, the activity
appears to be context- and cell type-dependent.16
WNT LIGANDS INVOLVED IN RENAL EPITHELIAL
DIFFERENTIATION
At least two WNT ligands, Wnt9b and Wnt4, are intimately
involved in the epithelial differentiation of metanephric
mesenchymal progenitors. Wnt9b is produced by the ureteric
bud and its genetic deletion in mice leads to severe kidney
hypoplasia, which is related, at least in part, to an arrest of
progenitor cell differentiation in the metanephric mesench-
yme.7 In Wnt9b mutant mice, the metanephric mesenchyme
is present; however, it fails to undergo the first step of
differentiation, namely formation of the pretubular aggre-
gate. As a result, the characteristic marker molecules of this
structure, such as Pax8, Fgf8, and Lhx1, are absent.
A second WNT ligand, Wnt4, is placed downstream of
Wnt9b signaling. The Wnt4 expression domain is confined to
the pretubular aggregate and early-stage epithelia derived
WNT-off state
Plasma
membrane
Plasma
membrane
FZD
WNT
FZD
DVL DVL
Degradation
complex
Axin
Axin
APC
APC
WTX
WTXUbiquitin
P
TLE/
Groucho HDAC Repression Transcription
TCF/Lef1 TCF/Lef1
Target gene Target gene
NucleusNucleus
P P P
PP
Proteasome
Proteasome
β-Catenin
β-Catenin
β-Cateninβ-Catenin
β-Catenin
β-Catenin
GSK3β
GSK3β
LRP LRP
WNT-on state
Figure 1 | Canonical WNT signaling. WNT—off state: In the absence of WNT ligands a b-catenin degradation complex (containing
axin, APC (adenomatous polyposis coli), WTX, and GSK3b) promotes N-terminal phosphorylation of b-catenin. This leads to
ubiquitin-mediated proteasomal degradation of b-catenin and keeps intracellular levels low. Meanwhile, TCF/Lef1 type transcription factors
recruit TLE/Groucho and histone deacetylases (HDAC) to repress WNT target genes. WNT—on state: Once WNT ligands bind to FZD
(Frizzled)/LRP (lipoprotein receptor-related protein) co-receptors, the b-catenin degradation complex is inhibited through recruitment of its
components to the FZD/LRP/DVL (Dishevelled) complex. Consequently, b-catenin accumulates intracellularly, translocates to the
nucleus, and displaces TLE/Groucho from TCF/Lef1. This interaction promotes the transcription of WNT target genes.
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subsequently. Similar to Wnt9b mutants, Wnt4 gene-deleted
mouse embryos display pronounced kidney hypoplasia and a
near-complete arrest of tubulogenesis at the stage of the
pretubular aggregate with only few progenitor cells convert-
ing into more advanced stages of nephron formation.6,17
Remarkably, a loss-of-function WNT4 mutation has recently
been implicated in a severe renal hypoplasia syndrome in
humans, indicating that this molecule has a conserved role in
mammalian kidney development.18 More generally, this
observation is the first piece of evidence supporting the
notion that defective WNT signaling in epithelial progenitors
participates in human congenital diseases of the kidney.
When metanephric mesenchymes from mouse or rat
embryos are isolated from the ureteric bud and placed in
organ culture, they undergo rapid apoptosis and fail to
convert into epithelia unless they are recombined with either
the ureteric bud or surrogate stimuli. Remarkably, WNT
ligands (including Wnt4 and Wnt9b), when expressed from
co-cultured fibroblasts placed adjacent to the metanephric
mesenchyme provide such surrogate stimuli. As a result, the
mesenchyme survives and undergoes complete conversion
into nephron-like epithelia in their presence.5,7,19 Indeed,
these data suggest that Wnt9b fulfills the criteria of the
ureteric bud-derived metanephric mesenchyme inducer that
was proposed over half a century ago.20 Yet, a note of caution
should be made when interpreting the available data. First,
the epithelial progenitors in the metanephric mesenchyme
remain viable and detectable in Wnt9b mutant mice, as
determined by Pax2 and Gdnf staining.7 This state of affairs
contrasts to what is observed in organ culture after removal
of the ureteric bud. This finding suggests that additional
factors emanating from the ureteric bud ensure survival of
these progenitors. Also, the data obtained by use of WNT-
expressing fibroblasts as a source of the WNT ligands leaves
open questions. For instance, to elicit their anti-apoptotic
and differentiation-inducing activity WNT ligands must be
expressed from co-cultured fibroblasts that are in direct
contact with the isolated metanephric mesenchymal pro-
genitors.5 Supernatants from WNT-expressing cells alone are
ineffective as are recombinant WNT proteins.21 Furthermore,
the type of cell line used for WNT protein expression in co-
culture experiments appears to affect the outcome.7 These
observations suggest that WNT ligands may require addi-
tional co-factors to elicit their full survival and differentia-
tion-inducing activity. Direct overexpression of WNT ligands
in the isolated metanephric mesenchyme in a feeder-free
system may resolve these issues, but has not been attempted.
Despite these reservations, WNT ligands clearly constitute
central players in the course of nephron development.
THE ROLE OF b-CATENIN/TCF/LEF1 SIGNALING IN NEPHRON
INDUCTION AND EPITHELIAL DIFFERENTIATION
Is b-catenin/TCF/Lef1 signaling necessary for WNT-depen-
dent effects in the metanephric mesenchyme? Conditional
b-catenin gene deletion in the metanephric mesenchyme in
mice leads to marked renal hypoplasia and a reduction in
several direct or indirect target genes, including Pax8, Wnt4,
Fgf8, and Lhx1. 22 Nephron numbers are markedly reduced in
these mutant kidneys and the few nascent nephrons observed
in these animals may form as a result of incomplete b-catenin
gene deletion.22 Overall, the phenotype of metanephric
mesenchymal b-catenin mutants resembles that of Wnt9b
mutants suggesting an involvement of b-catenin downstream
of Wnt9b. Is this effect mediated by TCF/Lef1 transcription
factors? Although direct in vivo data are missing, rat
metanephric mesenchymal cells induced to express a
dominant-negative N-terminal truncation mutant of TCF
undergo apoptosis and are progressively depleted in the
organ culture model of metanephric mesenchymal differ-
entiation.9 Taken together, these data suggest a model in
which a WNT/b-catenin/TCF/Lef1 signaling axis in the
metanephric mesenchyme is required for the formation of
the pretubular aggregate and thus a prerequisite for nephron
development.
Is b-catenin/TCF/Lef1 signaling sufficient to trigger
epithelial conversion from metanephric mesenchymal pro-
genitors? Lithium chloride and bromoindirubin-30-oxime,
both GSK3b inhibitors, are each sufficient to prevent apop-
tosis and induce the appearance of nephron-like epithelia
expressing polarity markers such as E-cadherin when applied
to isolated metanephric mesenchyme. The inhibitors appear
to ‘phenocopy’ the effect of WNT-expressing cell lines and
other surrogate inducers.9,23,24 This effect is associated with
increased levels of cytoplasmic b-catenin and the induction
of two putative b-catenin/TCF/Lef1 target genes in the
metanephric mesenchyme, namely Tcf7 (often referred to as
Tcf-1) and Lef1.23 These data suggest that WNT-induced
GSK3b inhibition may be a key mechanism in nephron
differentiation and that stabilization of b-catenin may be
involved in this activity. In addition, combinations of non-
WNT growth factors, including either leukemia inhibitory
factor or transforming growth factor-b2, are sufficient to
activate nephron differentiation in isolated rat metanephric
mesenchyme, which is accompanied by binding of TCF/Lef1
consensus oligos by nuclear extracts of these progenitors.8
Furthermore, leukemia inhibitory factor activates a set
of direct b-catenin/TCF/Lef1 target genes in rat metanephric
mesenchyme, including Pax8, Emx2, and Ccnd1, which may
be secondary to a leukemia inhibitory factor-induced
upregulation of Wnt4 expression.9 These data suggest that
WNT/b-catenin/TCF/Lef1 signaling may be a common
pathway activated by all nephron-inducing growth factors
thus far identified.
However, WNT ligands, inhibitors of GSK3b, and induc-
tive growth factors may trigger important intracellular events
in epithelial progenitors other than the stabilization of
b-catenin. Importantly, the WNT/GSK3b axis has recently
been shown to activate intracellular signaling independent
of b-catenin stabilization.25 To differentiate b-catenin-
dependent from b-catenin-independent effects, genetically
stabilized b-catenin mutants are used to facilitate a pure
activation of the b-catenin pathway and to omit effects on
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other GSK3b targets.26 Interestingly, the conditional
b-catenin stabilization in metanephric mesenchymal epithe-
lial progenitor cells in vivo leads to the formation of ectopic
cell aggregates that express markers of the pretubular
aggregate, including Pax8, Wnt4, Fgf8, and Lhx1.22 This
effect is also observed on a Wnt9b- or Wnt4-deficient genetic
background.22 The finding suggests that b-catenin stabiliza-
tion is a sufficient mechanism by which these WNT ligands
initiate renal epithelial cell lineage progression up to the
pretubular aggregate stage. Similarly, when b-catenin is
stabilized in the isolated metanephric mesenchyme placed
in organ culture, the cells escape apoptosis, proliferate, and
initiate pretubular aggregate marker expression.9,22,23 Re-
markably, polarized epithelia are observed in neither setting.
In fact, E-cadherin expression is completely absent in the cell
aggregates induced by stabilization of b-catenin.9,22 More-
over, when b-catenin is stabilized in the metanephric
mesenchyme in vivo, the cellular transition to epithelial
structures is completely blocked, even in the presumed presence
of endogenous ureteric bud-derived inductive signals.22 In
addition, the differentiation-inducing effect of GSK-3b inhibi-
tors in the isolated metanephric mesenchyme is only present
when these agents are applied transiently or at low dosages,
whereas high dosages block differentiation.9,23 Together, these
data suggest that b-catenin/TCF/Lef1 signaling may in fact be
antagonistic to the epithelial conversion of pretubular aggre-
gates. This model is consistent with the observation that
b-catenin/TCF/Lef1 signaling inhibits differentiation features
in cultured epithelial cells from other lineages.27,28
These observations may be relevant not only in the setting
of normal renal organogenesis, but also during tumorigen-
esis. Notably, stabilization of b-catenin is frequently observed
in Wilms tumor, a common pediatric kidney malignancy,
which is thought to be initiated in ‘nephrogenic rests’, that is,
islands of persistent blastema in the otherwise fully developed
kidney.29 Ten to fifteen percent of Wilms tumors display
oncogenic mutations of b-catenin.30 Another one third
of Wilms tumors are related to inactivating mutations of
the X-linked tumor suppressor gene WTX,31 which normally
associates with the b-catenin degradation complex and
promotes b-catenin disposal (Figure 1).32 Blastemal regions
of Wilms tumors express a series of genes also expressed
in the metanephric mesenchyme.2,33 Suggesting that the
response of these cells to an activation of b-catenin/TCF/Lef1
signaling may be similar. Thus, in analogy to its effects in the
metanephric mesenchyme, b-catenin signaling may contri-
bute to the differentiation arrest in Wilms tumors and—
at the same time—promote cellular proliferation.
Interestingly, b-catenin/TCF/Lef1 signaling has also
recently been implicated in ureteric bud epithelial differen-
tiation. In contrast to the differentiation of the proximal
nephron from mesenchymal progenitors, the ureteric bud
is formed by budding from a pre-existing epithelial tube,
the Wolffian duct. Although all cells of the ureteric bud
have already undergone epithelial conversion, the more
immature distal branches express several genes associated with
branching morphogenesis, such as Ret and Wnt11,34 but lack
several markers of terminal collecting duct differentiation,
namely aquaporin 3 or ZO-1aþ .35 A conditional b-catenin
gene deletion in the ureteric bud causes premature terminal
epithelial differentiation even in the distal-most tips, which is
associated with a defect of ureteric branching morphogenesis
and severe renal hypoplasia/dysplasia.35,36 Furthermore,
conditional b-catenin stabilization in the ureteric bud anta-
gonizes terminal differentiation of collecting duct epithelia.35
These data suggest a more general model, where b-catenin/
TCF/Lef1 signaling in the renal epithelial lineage is associated
with ongoing morphogenesis but inhibitory to terminal
differentiation.
These bimodal b-catenin signaling effects are consistent
with studies of in vivo TCF/Lef1 signaling activity in mice
that express b-galactosidase reporters driven by TCF/Lef1-
responsive promoters.9,37,38 Their activity is confined to the
immature regions of the ureteric bud and to early-stage
metanephric mesenchymal-derived epithelia, but becomes
undetectable in the more mature portions of the nephron.
Whereas all in vivo TCF/Lef1 reporters appear to display
some context-dependent differences in sensitivity and
specificity,39 this model is also supported by the expression
patterns of b-catenin/TCF/Lef1 target genes, including Pax8,
Emx2, and Ccnd1.9,36
One challenge for future studies will be to more
thoroughly elucidate the consequences of this temporal and
spatial b-catenin/TCF/Lef1 signaling activity window in the
course of nephron formation. An intriguing hypothesis is
that the appropriate balance of b-catenin/TCF/Lef1 signaling
and non-canonical WNT/PCP signaling is critical for
terminal epithelial differentiation, as well as proper tubular
elongation and nephron patterning. Defects in epithelial
differentiation in nephron progenitors that express stabilized
b-catenin may possibly be related to a disrupted balance of
the two WNT signal transduction branches. This idea is
supported by experiments carried out in a recently developed
colony-forming assay system of clonally isolated metanephric
mesenchymal progenitors that are co-cultured with Wnt4-
expressing fibroblasts.21 In these progenitors, inhibition of
Jun N-terminal kinase, a late step in PCP signaling, impairs
E-cadherin-positive epithelial cell differentiation suggesting a
requirement of PCP signaling for terminal epithelial
differentiation. Furthermore, in epithelia that have completed
terminal differentiation, constitutive b-catenin signaling
activation by conditional adenomatous polyposis coli in-
activation or overexpression of stabilized b-catenin promotes
the development of epithelial cysts. These cysts display
characteristic apical–basal polarity defects, which may be
indicative of a differentiation defect.40,41 Consistently, several
molecules that inhibit cystogenesis, including the ciliary
proteins inversin, Bbs4, and Kif3a, have since been identified
as negative b-catenin/TCF/Lef1 signaling regulators.42–44 In
the case of inversin and Bbs4, a reciprocal modulation of PCP
signaling has been demonstrated.42,43 These data point to an
intricately coordinated molecular machinery in developing
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and mature renal epithelia that controls the balance of the
two WNT signaling branches. However, a more direct
characterization of PCP signaling and b-catenin/TCF/Lef1
signaling and their interaction is warranted to definitively
establish their individual contributions.
Although many open questions remain, the fact that
WNT/b-catenin signaling is a necessary and sufficient trigger
of the early stages of nephron differentiation is now clear. The
perspectives for the future will be threefold: (1) to delineate
the role of b-catenin at later stages of epithelial development;
(2) to elucidate the detailed roles of additional WNT/GSK3b-
dependent and non-canonical WNT pathways; and, (3) to
dissect WNT-dependent from WNT-independent mecha-
nisms by additional methods.
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